Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. announced that it has received funding of CNY 370 million on December 30, 2022. The investment was coled by the new investors Shenzhen Qianhai Xinyi Yide Fund Management Co., Ltd. and Qingchi Capital. The other investors were Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317), Guangdong Boguan Yuanchuang Biotechnology Research Center (Limited Partnership), Wanlian Guangsheng Investment Co., Ltd. and Guangzhou Guoju Venture Capital Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.9 CNY | +2.19% | +3.98% | -7.17% |
Apr. 22 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 11 | Zhongsheng Pharma's Chairman to Raise Stake in Company | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.17% | 1.74B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002317 Stock
- News Guangdong Zhongsheng Pharmaceutical Co., Ltd.
- Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. announced that it has received CNY 370 million in funding from Guangdong Zhongsheng Pharmaceutical Co., Ltd., Guangdong Boguan Yuanchuang Biotechnology Research Center (Limited Partnership), Wanlian Guangsheng Investment Co., Ltd., Guangzhou Guoju Venture Capital Co., Ltd., Qingchi Capital, Shenzhen Qianhai Xinyi Yide Fund Management Co., Ltd.